567616 Sodium 4-Phenylbutyrate - CAS 1716-12-7 - Calbiochem

567616
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service
      View Pricing & Availability

      Overview

      Replacement Information

      Key Specifications Table

      Empirical FormulaCAS #
      C₁₀H₁₁O₂Na 1716-12-7

      Pricing & Availability

      Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
      567616-100MG
      Retrieving availability...
      Limited AvailabilityLimited Availability
      Stocked 
      Discontinued
      Limited Quantities Available
      Available
        Remaining : Will advise
          Remaining : Will advise
          Will advise
          Contact Customer Service
          Contact Customer Service

          Plastic ampoule 100 mg
          Retrieving price...
          Price could not be retrieved
          Minimum Quantity needs to be mulitiple of
          Upon Order Completion More Information
          You Saved ()
           
          Request Pricing
          Description
          OverviewA novel anti-neoplastic agent and transcriptional regulator. Also acts as an inducer of tumor cytostasis and differentiation. Increases fetal hemoglobin production in vitro and in vivo.
          Catalogue Number567616
          Brand Family Calbiochem®
          SynonymsSPB, PBNa, 4PBA, 4-Phenylbutyrate, Na, BDK Inhibitor I, BCKD Kinase Inhibitor I, Branched-Chain α-Ketoacid Dehydrogenase Kinase Inhibitor I
          References
          ReferencesTso, S.C., et al. 2013. Proc. Natl. Acad. Sci. USA 110, 9728.
          Ozcan, U., et al. 2006. Science 313, 1137.
          Carducci, M.A., et al. 2001. Clin. Cancer Res. 7, 3047.
          Rubenstein, R.C. and Zeitlin, P.L. 2000. Am.J. Physiol. Cell. Physiol. 278, C259.
          Lea, M.A., et al. 1999. Anticancer Res. 19, 1971.
          Miller, A.C., et al. 1997. Int. J. Radiat. Biol. 72, 211.
          Rubenstein, R.C., et al. 1997. J. Clin. Invest. 100, 2457.
          Pineau, T., et al. 1996. Biochem. Pharmacol. 52, 659.
          Collins, A.F., et al. 1995. Blood 85, 43.
          Lea, M.A., et al. 1995. Anticancer Res. 15, 879.
          Figg, W.D., et al. 1994. Anticancer Drugs 5, 336.
          Liu, L., et al. 1994. J. Invest. Dermatol. 103, 335.
          Product Information
          CAS number1716-12-7
          ATP CompetitiveN
          FormWhite to slightly yellow solid
          Hill FormulaC₁₀H₁₁O₂Na
          Chemical formulaC₁₀H₁₁O₂Na
          Hygroscopic Hygroscopic
          ReversibleN
          Structure formula ImageStructure formula Image
          Applications
          ApplicationSodium 4-Phenylbutyrate, CAS 1716-12-7, is a novel anti-neoplastic agent and transcriptional regulator. Also acts as an inducer of tumor cytostasis and differentiation.
          Biological Information
          Primary TargetAnti-neoplastic agent
          Purity≥98% by Assay
          Physicochemical Information
          Cell permeableN
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage -20°C
          Hygroscopic Hygroscopic
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Sodium 4-Phenylbutyrate - CAS 1716-12-7 - Calbiochem SDS

          Title

          Safety Data Sheet (SDS) 

          Sodium 4-Phenylbutyrate - CAS 1716-12-7 - Calbiochem Certificates of Analysis

          TitleLot Number
          567616

          References

          Reference overview
          Tso, S.C., et al. 2013. Proc. Natl. Acad. Sci. USA 110, 9728.
          Ozcan, U., et al. 2006. Science 313, 1137.
          Carducci, M.A., et al. 2001. Clin. Cancer Res. 7, 3047.
          Rubenstein, R.C. and Zeitlin, P.L. 2000. Am.J. Physiol. Cell. Physiol. 278, C259.
          Lea, M.A., et al. 1999. Anticancer Res. 19, 1971.
          Miller, A.C., et al. 1997. Int. J. Radiat. Biol. 72, 211.
          Rubenstein, R.C., et al. 1997. J. Clin. Invest. 100, 2457.
          Pineau, T., et al. 1996. Biochem. Pharmacol. 52, 659.
          Collins, A.F., et al. 1995. Blood 85, 43.
          Lea, M.A., et al. 1995. Anticancer Res. 15, 879.
          Figg, W.D., et al. 1994. Anticancer Drugs 5, 336.
          Liu, L., et al. 1994. J. Invest. Dermatol. 103, 335.
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision14-July-2017 JSW
          SynonymsSPB, PBNa, 4PBA, 4-Phenylbutyrate, Na, BDK Inhibitor I, BCKD Kinase Inhibitor I, Branched-Chain α-Ketoacid Dehydrogenase Kinase Inhibitor I
          DescriptionAn antineoplastic agent that demonstrates potent differentiating capacity in multiple hematopoietic and solid tumor cell lines. Acts as an inducer of tumor cytostasis and differentiation as well as of peroxisomal proliferation. A more effective inhibitor of histone deacetylase and inducer of histone acetylation than its structural analogs including 2- and 3-phenylbutyrate. Acts as a transcriptional regulator and improve the targeting of δF508-CFTR (cystic fibrosis transmembrane regulator) for ubiquitination and degradation by reducing the expression of HSC70 in epithelial cells. Also, reported to increase fetal hemoglobin production in vitro and in vivo.
          FormWhite to slightly yellow solid
          CAS number1716-12-7
          Chemical formulaC₁₀H₁₁O₂Na
          Structure formulaStructure formula
          Purity≥98% by Assay
          SolubilityH₂O (10 mg/ml)
          Storage -20°C
          Hygroscopic
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Toxicity Standard Handling
          ReferencesTso, S.C., et al. 2013. Proc. Natl. Acad. Sci. USA 110, 9728.
          Ozcan, U., et al. 2006. Science 313, 1137.
          Carducci, M.A., et al. 2001. Clin. Cancer Res. 7, 3047.
          Rubenstein, R.C. and Zeitlin, P.L. 2000. Am.J. Physiol. Cell. Physiol. 278, C259.
          Lea, M.A., et al. 1999. Anticancer Res. 19, 1971.
          Miller, A.C., et al. 1997. Int. J. Radiat. Biol. 72, 211.
          Rubenstein, R.C., et al. 1997. J. Clin. Invest. 100, 2457.
          Pineau, T., et al. 1996. Biochem. Pharmacol. 52, 659.
          Collins, A.F., et al. 1995. Blood 85, 43.
          Lea, M.A., et al. 1995. Anticancer Res. 15, 879.
          Figg, W.D., et al. 1994. Anticancer Drugs 5, 336.
          Liu, L., et al. 1994. J. Invest. Dermatol. 103, 335.